Contrast media-induced nephrotoxicity - Questions and answers

British Journal of Radiology

Volumn 71, Issue APR., 1998, Pages 357-365

  Morcos, S K ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; ENDOTHELIN; NITRIC OXIDE; PROSTAGLANDIN; THEOPHYLLINE; VASODILATOR AGENT;

CELL VACUOLE; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DEHYDRATION; DIABETIC NEPHROPATHY; FEEDBACK SYSTEM; GLOMERULUS FILTRATION RATE; HENLE LOOP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY VASCULAR RESISTANCE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; OSMOLALITY; REVIEW; RISK FACTOR;

EID: 0031966685     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.71.844.9659127     Document Type: Review

References (85)

1. Byrd L, Sherman RL. Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review. Medicine 1979;58:270-9.
2. Deray G, Jacobs C. Radiocontrast nephrotoxicity; A review. Invest Radiol 1995;30:221-5.
3. Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989;36:730-40.
4. Golman K, Almen T. Contrast media-induced nephrotoxicity, survey and present state. Invest Radiol 1985;20:S92-7.
5. Brezis M, Epstein FH. A closer look at radiocontrast-induced nephropathy. N Engl J Med 1989;320:179-81.
6. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990;89:615-20.
7. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994;5:125-37.
8. Idee JM, Beaufils H, Bonnemain B. Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention. Fundam Clin Pharmacol 1994;8:193-206.
9. Porter GA. Radiocontrast-induced nephropathy. Nephrol Dial Transpl 1994;9:146-56.
10. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism - a clinical review. Am J Kidney Dis 1994;24:713-27.
11. Rudnik MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995;47:254-61.
12. Katzberg RW. What do we really know about contrast medium-induced acute renal failure? Invest Radiol 1989;24:219-20.
13. Dawson P, Trewhella M. Intravascular contrast agents and renal failure. Clin Radiol 1990;41:373-5.
14. Schwab SJ, Hlatky MA, Piper KS, et al. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and ionic radiographic contrast agent. N Engl J Med 1989;320:149-53.
15. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 1989;320:143 9.
16. Heyman SN, Brezis M, Reubinoff CA, et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest 1988;82:401-12.
17. Margulies KB, McKinley LJ, Cavero PG, Burnett JC. Induction and prevention of radiocontrast-induced nephropathy in dogs with heart failure. Kidney Int 1990;38:1101-8.
18. Brown P, Haylor JL, El Nahas AM, Morcos SK. The functional effects of contrast media on the isolated perfused rat kidney. Contrib Nephrol 1993;101:235-40.
19. Agmon Y, Peleg H, Greenfield Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994;94:1069-75.
20. Morcos SK, Brown PWG, Oldroyd S, El Nahas AM, Haylor J. Relationship between the diuretic effect of radiocontrast media and their ability to increase renal vascular resistance. Br J Radiol 1995;68:850-3.
21. Idee MJ, Bonnemain B. Reliability of experimental models of iodinated contrast media-induced acute renal failure: from methodological considerations to pathophysiology. Invest Radiol 1996;31:230-41.
22. Dawson P. On the nephrotic potential of the iodinated intravascular agents. Adv X-ray Contrast 1993;1:2-9.
23. Morcos SK, Epstein FH, Haylor J, Dobrota M. Aspects of contrast media nephrotoxicity. Eur J Radiol 1996;23:178-84.
24. Berg KJ, Jakobsen JA. Nephrotoxicity related to X-ray contrast media. Adv X-ray Contrast 1993;1:10-18.
25. Blomely MJK, Dawson P. The quantification of renal function with enhanced computed tomography. Br J Radiol 1996;69:989-95.
26. Love L, Johnson MS, Bresler ME, et al. The persistent computed tomography nephrogram: its significance in the diagnosis of contrast-associated nephrotoxicity. Br J Radiol 1994;67:951-7.
27. Jakobsen JA, Lundby B, Kristoffersen DT, Borch KW, Hald JK, Berg KJ. Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers. Radiology 1992;182:419-24.
28. Moore RD, steinberg EP, Powe NR, et al. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 1992;182:649-55.
29. Barrett JB, Parfrey PS, Vavasour HM, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992;41:1274-9.
30. Katholi RE, Taylor GJ, Woods WT, et al. Nephrotoxicity of nonionic low-osmolality versus ionic high-osmolality contrast media: a prospective double blind randomized comparison in human beings. Radiology 1993;186:183-7.
31. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171-8.
32. Deray G, Jacobs C. Renal tolerance of nonionic dimers. Invest Radiol 1996;31:372-377.
33. Oldroyd S, Haylor J, Morcos SK, El Nahas AM. Reduced depression of renal function by iotrolan in the isolated rat kidney. Eur J Radiol 1994;18:64-9.
34. Oldroyd SD, Haylor JL, Morcos SK. Bosentan, an orally active endothelin antagonist: effect on renal response to contrast media. Radiology 1995;196:661-5.
35. Brown P, Haylor JL, Cope GH, El Nahas AM, Morcos SK. Effect of diatrizoate on the function of the isolated perfused rat kidney. Br J Radiol 1992;65:1011-7.
36. El-Sayed AA, Haylor JL, El Nahas AM, Salzano S, Morcos SK. Haemodynamic effects of water-soluble contrast media on the isolated perfused rat kidney. Br J Radiol 1992;64:435-9.
37. Osswald H, Muhlbauer B, Schenk F. Adenosine mediates tubuloglomerular feedback response: an element of metabolic control of kidney function. Kidney Int 1991;39 (Suppl. 32): S128-31.
38. Katzberg RW, Schulman G, Meggs L, et al. Mechanism of the renal response to contrast medium in dogs. Decrease in renal function due to hypertonicity. Invest Radiol 1983;18:74-80.
39. Katzberg RW, Pabico RC, Morris TW, et al. Effects of contrast media on renal function and subcellular morphology in the dog. Invest Radiol 1986;21: 64-70.
40. Ueda J, Nygren A, Hansell P, Ulfendahl HR. Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol 1993;34:83-7.
41. Dawson P, Freedman DB, Howell MJ, Hine AL. Contrast medium-induced acute renal failure and Tamm-Horsfall proteinuria. Br J Radiol 1984;57:577-9.
42. Nordby A, Tvedt KE, Halgunset J, Haugen OA. Intracellular penetration and accumulation of radiographic contrast media in the rat kidney. Scanning Microscopy 1990;4:651-66.
43. Powell CJ, Holtz E, Bridges JW. The nephrotoxicity of non-ionic and isosmotic dimeric radiological contrast media. J Pathol 1985;146:276A.
44. Tervahartiala P, Kivisaari L, Kivisaari R, Virtanen I, Standertskjold-Nordenstam CG. Contrast mediainduced renal tubular vacuolisation: A light and electron microscopic study on rat kidneys. Invest Radiol 1991;26:882-7.
45. Moreau JF, Droz D, Noel LH, Leibovitch J, Jungers P, Michel JR. Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol 1980;15:54-60.
46. Battenfeld R, Khater AR, Drommer W, Guenzel P, Kaup F-J. Ioxaglate-induced light and electron microscopic alterations in the renal proximal tubular epithelium of rats. Invest Radiol 1991;26:35-9.
47. Brezis M, Greenfield Z, Herman JJ, Meyer SN, Heyman SN, Rosen S. Experimental nephrotoxicity of radiocontrast agents iohexol, ioxaglate and iothalamate. Invest Radiol 1991;26:325-31.
48. Beeri R, Symon Z, Brezis M, Ben-Sasson SA, Baher PH, Rosen S, et al. Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 1995;47:1806-10.
49. Heyman SN, Rosen S, Brezis M. Radiocontrast nephropathy: a paradigm for synergism between toxic and hypoxic insults in the kidney. Exp Nephrol 1994;2:153-7.
50. Trewhella M, Dawson P, Forsling M, McCarthy P, O'Donnell C. Vaspressin release in response to intravenously injected contrast media. Br J Radiol 1990;63:97-100.
51. Liss P, Nygren A, Olsson U, Ulfendahl HR, Erikson U. Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int 1996;49:1268-75.
52. Nygren A, Ulfendahl HR, Hanscll P, Erikson U. Effects of intravenous contrast media on cortical and medullary blood flow in the rat kidney. Invest Radiol 1988;23:753-61.
53. Lund G, Einzig J, Salomonowitz E, et al. Effect of prostaglandin inhibition on the renal vascular response to ionic and non-ionic contrast media in the dog. Acta Radiol 1984;25:407-10.
54. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
55. Morcos SK, Oldroyd S, Haylor J. Effect of radiographic contrast media on endothelium derived nitric oxide-dependent renal vasodilatation. Br J Radiol 1997;70:154-9.
56. Vallance P, Collier J. Biology and clinical relevance of nitric oxide. Br Med J 1994;309:543-7.
57. Brezis ML, Heyman SN, Dinour D, Epstein FH, and Rosen S. Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J Clin Invest 1991;88:390-5.
58. Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993;44:1217-23.
59. Touati C, Idee JM, Deray G, et al. Modulation of renal effects of contrast media by endothelium-derived nitric oxide in the rat. Invest Radiol 1993;28:814-20.
60. Cadicott WJH, Hollenberg NK, Abrams HL. Characteristics of response of renal vascular bed to contrast media: evidence of vasoconstriction induced by renin-angiotensin system. Invest Radiol 1970;5:539-47.
61. Katzberg RW, Meggs LG, Schulman G, Hollenberg NK. Contrast medium induced renal vasoconstriction and endogenous vasoconstrictor hormones, Br J Radiol 1982;55:266-8.
62. Arend LJ, Bakris JC, Burnett JC, Megerian C, Spielman WS. Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 1987;110:406-11.
63. Margulies KB, Hildebrand FLJ, Heublein DM, Burnett JCJ. Radiocontrast increases plasma and urinary endothelin. J Am Soc Nephrol 1991;2:1041-45.
64. Heyman SN, Clark BA, Kaiser N, et al. Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 1992;3:58-65.
65. Marguiles KB, McKinley LJ, Burnett JC. Endothelin in human and canine radiocontrast-induced nephropathy. J Vasc Res 1992;29:163-4.
66. Heyman SN, Clark BA, Cantley L, Spokes K, Rosen S, Brezis M, et al. Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy. Invest Radiol 1993;28:313-8.
67. Oldroyd S, Slee SJ, Haylor J, Morcos SK, Wilson C. Role for endothelin in the renal response to radiocontrast media in the rat. Clin Sci 1994;87:427-4.
68. Oldroyd SD, Haylor JL, Morcos SK. The acute effect of ioversol on kidney function: role of endothelin. Eur J Radiol 1995;19:91-5.
69. Brooks DP, Dennis DePalma P. Blockade of radiocontrast-induced nephrotoxicity by endothelin receptor antagonist, SB209670. Nephron 1996;72:629-36.
70. Yanagisawa M, Kurihara H, Kimura S, et al. A novel vasoconstrictor peptide produced by endothelial cells. Nature (London) 1988;332:411-5.
71. Remuzzi G, Benigni A. Endothelins in the control of cardiovascular and renal function. Lancet 1993;342:589-93.
72. Kohan DE. Endothelins in the kidney: physiology and pathophysiology. Am J Kidney Dis 1993;22:493-510.
73. Arakawa K, Suzuki H, Naitoh M, et al. Role of adenosine in the renal responses to contrast medium. Kidney Int 1996;49:1199-206.
74. Katholi RE, Taylor GJ, McCann WP, et al. Nephrotoxicity from contrast media: attenuation with theophylline. Radiology 1995;195:17-22.
75. Erley CM, Duda SH, Schlepckow S, et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 1994;45:1425-31.
76. Erley CM, Burgert K, Langanke J, Osswald H, Risler T. A novel animal model of radiocontrastinduced nephropathy (RCN). J Am Soc Nephrol 1995;5:426.
77. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20.
78. Golman K, Cederholm C. Contrast medium-induced renal failure, can it be prevented? Invest Radiol 1990;25:S127-8.
79. Bentley MD, Fiksen-Olsen MJ, Romero JC. Effect of atriopeptin II on contrast medium-induced changes in renal blood flow. Kidney Int 1989;36:13-9.
80. Kurnik BRC, Weisberg LS, Cuttler IM, Kurnik P. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure. J Lab Clin Med 1990;116:27-35.
81. Hans B, Hans SS, Mittal VK, Khan TA, Patel N, Dahn MS. Renal functional response to dopamine during and after arteriography in patients with chronic renal insufficiency. Radiology 1990;176:651-4.
82. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994;45:259-65.
83. Neumayer HH, Junge W, Kufner A, Wenning A. Prevention of radiocontrast - media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. Nephrol Dial Transpl 1989;4:1030 6.
84. Carraro M, Mancini W, Artero M, et al. Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. Nephrol Dial Transpl 1996;11:444-8.
85. Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 1994;331:1449-50.